文献速递冠心病

CT冠状动脉造影助力CABG术后NSTE-ACS的临床决策与选择性侵入性造影

Computed tomography coronary angiography to facilitate clinical decision-making and selective invasive angiography in patients with prior bypass grafting presenting with acute coronary syndromes.
PubMed 文献 · Heart · 2026-01-27

针对既往CABG的NSTE-ACS患者,BYPASS-CTCA研究让50名介入心脏病专家审阅150例匿名病例。仅凭临床信息时治疗策略一致性差(κ=0.14),加入CTCA报告后一致性提升至中等(κ=0.53,p<0.001),药物治疗选择从13.2%升至39.3%(p<0.001),支持CTCA引导策略的前瞻性评估。

要点

  • 仅凭临床信息,专家对CABG术后NSTE-ACS管理策略一致性差(κ=0.14)。
  • 加入CTCA后一致性提升至中等(κ=0.53),药物治疗选择增至39.3%。
  • CTCA后选择侵入性管理时,85%病例需PCI,79%计划选择性造影。

核心结论

  • 既往CABG的NSTE-ACS患者管理决策在经验丰富的心脏病专家间差异很大。
  • 将CTCA纳入诊断路径可显著提高管理共识、减少不必要的侵入性造影并支持靶向低风险操作。
  • 这些发现支持在前瞻性随机试验中评估CTCA引导策略。

研究设计与样本

  • BYPASS-CTCA随机对照试验的亚组分析,纳入150例既往CABG的NSTE-ACS患者。
  • 50名经验丰富的介入心脏病专家(中位资质17年)独立审阅匿名病例和CTCA报告,共5103次病例审阅。
  • 使用Fleiss κ统计评估CTCA前后管理策略的一致性。

主要发现

  • 仅基于临床信息,受访者选择药物治疗的比例为13.2%,管理策略一致性差(κ=0.14,95%CI 0.11-0.17)。
  • 审阅CTCA后,一致性提升至中等(κ=0.53,95%CI 0.48-0.58;p<0.001),药物治疗选择比例为39.3%(p<0.001)。
  • CTCA后选择侵入性管理时,85%病例需要PCI,79%计划采用选择性造影方法。

临床怎么用

  • 对既往CABG的NSTE-ACS患者,可考虑将CTCA纳入诊断路径以辅助决策。
  • CTCA有助于识别可从侵入性造影中获益的患者并减少不必要的侵入性操作。

局限性

  • 本研究为基于病例 vignette 的专家审阅分析,非真实临床结局研究。
  • 结论支持需前瞻性随机试验进一步验证CTCA引导策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with prior coronary artery bypass grafting (CABG) account for around 10% of non-ST-elevation acute coronary syndromes (NSTE-ACS), but the optimal diagnostic and management strategy remains uncertain. Invasive coronary angiography (ICA) in this group is technically challenging, carries increased risk and often does not lead to percutaneous coronary intervention (PCI). CT coronary angiography (CTCA) may help identify which patients benefit from ICA and reduce unnecessary invasive procedures. METHODS: In the BYPASS-CTCA (Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients) study, patients with prior CABG undergoing ICA were randomised to CTCA plus ICA or ICA alone. For this analysis, anonymised case vignettes and CTCA reports from 150 patients with NSTE-ACS were independently reviewed by 50 experienced interventional cardiologists (median 17 years post-qualification; 5103 total case reviews). Agreement on management strategy before and after CTCA was assessed using Fleiss' κ statistic. RESULTS: Based on clinical information alone, respondents chose medical therapy in 13.2% of cases, with poor agreement on management strategy (κ=0.14, 95% CI 0.11 to 0.17). After reviewing CTCA, agreement improved to moderate (κ=0.53, 95% CI 0.48 to 0.58; p<0.001), and medical management was selected in 39.3% (p<0.001). When invasive management was selected post-CTCA, PCI was required in 85% of cases, and a selective angiographic approach was planned in 79%. CONCLUSIONS: Management decisions for post-CABG NSTE-ACS vary widely among experienced cardiologists. Incorporating CTCA into the diagnostic pathway substantially improves consensus, reduces unnecessary invasive angiography and enables targeted, lower-risk procedures. These findings support evaluation of a CTCA-guided strategy in a prospective randomised trial.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Kelham, Beirne, Learoyd, et al. Computed tomography coronary angiography to facilitate clinical decision-making and selective invasive angiography in patients with prior bypass grafting presenting with acute coronary syndromes. Heart. 2026. PMID: 41592807. doi:10.1136/heartjnl-2025-326961

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。